Skip to main content
Indian Journal of Urology : IJU : Journal of the Urological Society of India logoLink to Indian Journal of Urology : IJU : Journal of the Urological Society of India
. 2007 Apr-Jun;23(2):114–118. doi: 10.4103/0970-1591.32058

Clinical evaluation of a simple uroflowmeter for categorization of maximum urinary flow rate

Simon Pridgeon *,^, Christopher Harding *, Douglas Newton , Robert Pickard *,§,
PMCID: PMC2721516  PMID: 19675784

Abstract

Objective:

To evaluate the accuracy and diagnostic usefulness of a disposable flowmeter consisting of a plastic funnel with a spout divided into three chambers.

Materials and Methods:

Men with lower urinary tract symptoms (LUTS) voided sequentially into a standard flowmeter and the funnel device recording maximum flow rate (Qmax) and voided volume (Vvoid). The device was precalibrated such that filling of the bottom, middle and top chambers categorized maximum input flows as <10, 10-15 and > 15 ml s−1 respectively. Subjects who agreed to use the funnel device at home obtained readings of flow category and Vvoid twice daily for seven days.

Results:

A single office reading in 46 men using the device showed good agreement with standard measurement of Qmax for Vvoid > 150 ml (Kappa = 0.68). All 14 men whose void reached the top chamber had standard Qmax > 15 ml s−1 (PPV = 100%, NPV = 72%) whilst eight of 12 men whose void remained in the bottom chamber had standard Qmax < 10 ml s−1 (PPV = 70%, NPV = 94%). During multiple home use by 14 men the device showed moderate repeatability (Kappa = 0.58) and correctly categorized Qmax in comparison to standard measurement for 12 (87%) men.

Conclusions:

This study suggests that the device has sufficient accuracy and reliability for initial flow rate assessment in men with LUTS. The device can provide a single measurement or alternatively multiple home measurements to categorize men with Qmax < 15 ml s−1.

Keywords: Bladder outlet obstruction, urinary symptoms, uroflowmetry


Measurement of maximum urinary flow rate (Qmax) is widely used in the assessment of men complaining of lower urinary tract symptoms (LUTS). Although Qmax varies with age and voided volume (Vvoid), a reduced flow rate can be used clinically to suggest the presence of bladder outlet obstruction (BOO). For clinical categorization cut-off values have been identified whereby men with Qmax ≤ 15 ml s−1 have an approximate 70% chance of having BOO whilst men with a value > 15 ml s−1 have a 65% chance of not having BOO.[1] Standard uroflowmeters differentiate urine weight change to give a continuous plot of flow rate against time which is smoothed by internal electronic filtering to allow precise (± 5%) measurement of Qmax.[2] Most clinicians use a single office measurement of flow rate as part of their assessment of men with LUTS but this approach may not be ideal because of physiological variation and nonrepresentative Vvoid.[3] Approaches to address these deficiencies include obtaining multiple office readings which may improve diagnostic accuracy but is time-consuming and costly[4] or provision of home electronic flowmeters which are also expensive and difficult to maintain.[5] Another possibility is home use of a disposable uroflowmetry device which enables multiple measurements in line with an individual's day-to-day voiding habits and could potentially be used as part of initial assessment of men with LUTS prior to specialist referral.[6] An ideal device would be accurate, simple to use and inexpensive. Prototype devices have been developed but, to our knowledge, are not being routinely used in practice.[6,7] Recently, a simple inexpensive funnel device has been made available which is potentially suitable for repeated measurement of maximum flow rate in the patient's home (Uflow meter™, MDTi Ltd, Wolverhampton, UK). We now describe the results of a clinical study which aimed to determine the accuracy and test-retest reliability of the new device in office and home settings with reference to the current standard of a single Qmax office-based reading.

MATERIALS AND METHODS

The device

The flow device consists of a plastic funnel formed from a cup and a spout divided into three chambers with a 4.6 mm diameter aperture placed at the apex [Figure 1]. Fluid poured into the cup will start to fill the funnel as well as flowing out through the aperture. Once inflow (determined by urine flow rate) and outflow (determined by the fixed-diameter aperture and the pressure-head of fluid above it) are equal, a constant maximal fluid level within the funnel will be maintained. With higher filling rates more fluid will be retained in the device and the fluid level will rise in the column provided that the time taken to reach the maximum level (response time) is substantially less than voiding time. Aperture diameter and volume of each chamber are calibrated such that filling of the bottom, middle and top (including cup) chambers corresponds to input flows of < 10, 10-15 and > 15 ml s−1 respectively to fit with the current clinical decision-making. The highest chamber reached by urine during the course of a void is recorded by the patient and categorizes their Qmax as being within the range for that chamber.

Figure 1.

Figure 1

Photographs of the device showing a, the 3-chamber design and b, the 4.6 mm aperture

Patients

Following Institutional and Local Research Ethics Committee approval and with informed consent, we recruited men with LUTS attending for standard office uroflowmetry. Each subject performed two sequential voids in a randomized order either into a standard rotating disc uroflowmeter (Urodyn 1000, Medtronic Ltd., Watford, UK) or into the portable funnel device. The patient held the funnel vertically with the spout above a measuring jug placed on the toilet seat lid to measure flow category and Vvoid. For the portable device flow category was derived from the highest chamber reached as observed by the patient and verified by the investigator. The printout from the standard flowmeter was manually read and Qmax taken at the highest point of the flow curve discounting spike artefact and with internal filtering set at 10Hz. Participants in the office study who used the portable device successfully and consented to home use were given a device, measuring jug and simple instruction sheet to record flows in a similar manner twice daily for seven days noting Qmax category and Vvoid on each occasion.

Data analysis

In order to assess the level of agreement between continuous data obtained by the standard uroflowmeter against categorical data obtained using the funnel device we assigned the Qmax value obtained by standard uroflowmetry to the appropriate category defined on the funnel device (≤10, >10 - ≤15 or >15 ml s−1) and then calculated the weighted Kappa statistic (chance corrected correlation coefficient) whereby Kappa > 0.4, > 0.6 and > 0.8 defines moderate, good and excellent agreement respectively. Test-retest reliability of home use of the device was also assessed using the Kappa statistic by comparing all home readings obtained by each individual to the most frequent flow category (mode) documented by that subject. The clinical usefulness of multiple home readings using the funnel device was determined by calculating the sensitivity and specificity of the average home flow against the reference of a single standard office measurement for the categories ≤15 and >15 ml s−1. Differences in voided volume were analyzed by paired Student's ‘t’ test with significance level set at P<0.05.

RESULTS

Office observations: Subjects

We recruited 46 men with median age 64 (range, 46-82) years, of whom 40 (87%) produced two consecutive flows with voided volume > 150 ml. Most subjects found the funnel device easy to use and read whilst five (11%) had difficulty due to obesity (n=3) or inability to observe the device and void simultaneously (n=2).

Accuracy

Figure 2 compares single measurements of Qmax obtained by the standard uroflowmeter and the funnel device. Men whose voids remained within the bottom chamber (< 10 ml s−1; n=12) had a mean (SD) Qmax with standard uroflowmetry of 9 (4.0) ml s−1, whilst voids that reached the middle chamber (10 - 15 ml s−1; n=20) or top chamber/cup (>15 ml s−1; n=14) had mean (SD) Qmax of 14 (4.0) ml s−1 and 24 (8.3) ml s−1 respectively. All 14 men with office funnel device readings in the top chamber or cup had Qmax > 15 ml s−1 using standard uroflowmetry (PPV = 100 %) whilst eight of the 10 men with standard Qmax < 10 ml s−1 were correctly categorized by the device [Table 1]. Overall single office measurement of Qmax by the funnel device showed good agreement with standard uroflowmetry (Kappa = 0.61). If data from six men with at least one Vvoid < 150 ml were excluded, the agreement level was improved (Kappa = 0.68). The mean (SD) difference between Vvoid for standard uroflowmeter reading and that for the funnel device reading was −17 (157 ml).

Figure 2.

Figure 2

Scatter plot showing the relationship between maximum flow rate (Qmax) readings obtained in the office using the standard uroflowmetry (vertical axis) and those obtained with the funnel device (horizontal axis). The mean of the single standard office measurements for subjects voiding within each funnel category is indicated by the horizontal bar

Table 1.

Accuracy of device in randomized clinic-based comparison with standard uroflowmetry according to Qmax thresholds

Funnel category Standard uroflowmetry Qmax (ml s−1) Predictive value (%)


< 10 10 - 15 > 15 PPV NPV
Bottom (<10 ml s−1) 8 3 1 70 94
Middle (10 - 15 s−1) 2 10 8 50 88
Top/cup (>15 ml s−1) 0 0 14 100 72

PPV = Positive predictive value; NPV = Negative predictive value

Home observations: Subjects

A total of 14 men with median age 64 (range, 50-81) years used the device at home and all completed the protocol of 14 Qmax and Vvoid recordings over seven days. None of these patients reported any difficulty in obtaining recordings using the device at home.

Accuracy

Averaged home readings using the funnel device correctly categorized seven of the nine men with standard Qmax > 15 ml s−1 (sensitivity = 78%, specificity = 71%) and all five men with a standard Qmax measurement ≤15 ml s−1 (sensitivity = 100%, specificity = 71%; [Figure 3]). For individual home readings the error in categorization compared to the reference office reading was significantly associated with lower Vvoid [Table 2]. Test-retest reliability using the funnel device was moderate (Kappa = 0.58). The mean (SD) difference between Vvoid for standard test and mean Vvoid for home uroflowmetry within each individual was −54 (67) ml.

Figure 3.

Figure 3

X-Y plot of the averaged notional home Qmax (horizontal axis) for 14 men against their single office-based standard reading (vertical axis). The broken lines show a diagnostic cut-off value of 15 ml s-1. Note plots for 12 of 14 (86%) subjects lie in the upper left or lower right quadrants indicating good agreement.

Table 2.

Comparison of the difference in voided volume (Vvoid) and the degree of error in estimation of standard single office Qmax by home use of the funnel device

Degree of error of home readings using funnel device compared to single office Qmax (number of funnel categories)

+2 +1 0 −1 −2
Number of voids 0 3 124 49 20
Mean (SD) difference in Vvoid(ml) −78 (185) −17 (113) −68 (139) P=0.01 −165 (109) P<0.001

Single office flow was assigned to appropriate funnel category and compared to each of the 14 home voids performed by each subject using the funnel device where 0 = same category as office reading, +1 = home reading 1 category higher than office reading, +2 = home reading 2 categories higher than office reading, −1 = home reading 1 category lower than office reading, −2 = home reading 2 categories lower than office reading. The difference in voided volume was calculated as: home Voffice Vvoid - office Vvoid

DISCUSSION

The ageing population and heightened awareness of prostate cancer have increased the number of men with LUTS requesting specialist assessment. This has led many urology practices to set up ‘one stop’ clinics facilitated by asking men to complete symptom questionnaires and frequency-volume charts prior to the office appointment. The addition of ‘home’ uroflow measurement to this preassessment would further streamline the process and help decide management options. The novel device assessed in the present study is potentially suited to this use since it appears to offer acceptable accuracy and reliability with ease of patient use at low cost.

For office use our device showed good agreement with standard measurement, particularly using established diagnostic cut-off values. Most discrepancies occurred due to underestimation by the device of flows in the 15-20 ml s−1 range. This may have been partly due to the tendency for lower Vvoid using the device despite randomization or may reflect the known test-retest variation in the standard measurement of Qmax (SD = 2 ml s−1).[8,9]

The home part of the study was conceived to assess both test-retest reliability of the device and predictive value of multiple recordings compared to a single electronic office measurement. The device showed moderate reliability as indicated by the Kappa statistic which may reflect the known variation of Qmax with voided volume and time of void[3] or readings being ‘borderline ‘between two chambers. In common with a previous study using a home-based electronic flowmeter our home device tended to underestimate a standard office measurement of Qmax.[5] Our data suggest that this may be at least partly related to lower home Vvoid and this again is consistent with previous work.[5,10] Encouragingly, agreement was best for flows ≤ 15 ml s−1 where diagnostic decisions will be crucial. If the new device was used at home as a ‘screen’ for onward referral for formal uroflowmetry underestimation of flow rates > 15 ml s−1 would be of less concern since this would not reduce test sensitivity for detection of flow ≤ 15 ml s−1. Taken together these findings suggest that multiple use of our simple uroflowmetry device does provide a valid and reasonably reliable measure of Qmax and that multiple readings using the device could be of potential use in the initial assessment of men with LUTS.

In terms of simplicity the device tested in the present study is intermediate between the very basic ‘Streamtest’ Cup proposed by Currie[7] and the more complicated multi-exit port device of Pel and van Mastrigt.[6] The device showed similar accuracy using different flow thresholds to the ‘Streamtest’ but inferior reliability to the multi-port device which was, however, tested on young noncomplaining volunteers with higher Vvoid. We feel that the ability of the funnel device to categorize men into widely used flow rate bands together with its manufacture using a single plastic molding combines low cost [estimated at $8.60 (≤ 5; £ 7.30) per unit] and acceptable accuracy making it suitable for disposable use prior to an office visit for men complaining of LUTS.

The addition of flow data to the widely used frequency volume chart completed prior to the initial office visit would greatly aid diagnosis and treatment planning. In the UK and other countries where all men are initially seen by a family care practitioner it could also be used to help select men for specialist referral. Men with most readings in the upper chamber or cup (notional average flow > 15 ml s−1) are unlikely to have BOO and alternative explanations for their symptoms should be sought or else they could be monitored in the community. Those with multiple flows in the middle or lower chambers (≤15 ml s−1) could be selected for urology referral and a formal flow assessment if required. Home flow measurements would also be useful for those patients who are unable to provide a representative void during an office visit. We next intend to establish the minimum number of ‘home’ flows required to give the best estimate of standard Qmax and then compare patient management with and without clinician use of the data generated.

CONCLUSION

This simple inexpensive uroflowmetry device allows multiple estimates of Qmax to be made in the home setting. The accuracy and reliability of the device appears sufficient to allow categorization around the standard threshold of 15 ml s−1 suggesting its usefulness in the preliminary assessment of men with LUTS prior to an office visit.

Acknowledgments

Manufacture of prototype devices used in this study was financed by the Business Development Unit, Newcastle University and RTC North, a branch of the UK NHS Research and Development Directorate. Clive Griffiths and Michael Drinnan, Department of Medical Physics, Freeman Hospital, Newcastle upon Tyne gave helpful advice on data analysis and constructive comments on the manuscript. We thank Philip Harley of Newcastle University for providing Figure 1. We thank the men who took part in the study and the staff of the urodynamic clinic, Freeman Hospital who helped with recruitment.

Footnotes

Source of Support: Business Development Unit, Newcastle University and RTC North

Conflict of Interest: None declared.

FORM IV

Statement about ownership and other particulars about newspaper (Indian Journal of Urology) to be published in the first issue every year after the last day of February

1. Place of publication : Mumbai
2. Periodicity of its publication : Quarterly (January, April, July and October)
3. Printer's Name : Medknow Publications Pvt. Ltd.
Nationality : Indian
Address : A-108/109, Kanara Business Center,
Off Link Rd, Ghatkopar (E),
Mumbai - 400075, India
Phone: 91-22-6649 1818/1816,
Fax: 91-22-6649 1817
4. Publisher's Name : Medknow Publications Pvt. Ltd.
Nationality : Indian
Address : A-108/109, Kanara Business Center,
Off Link Rd, Ghatkopar (E),
Mumbai - 400075, India
Phone: 91-22-6649 1818/1816,
Fax: 91-22-6649 1817
5. Editor's Name : Nitin S. Kekre
Nationality : Indian
Address : Department of Urology, Christian Medical College,
Vellore - 632 004, Tamil Nadu, India
Phone: +91-0416-2282111, Fax: +91- 0416 - 2232035,
E-mail: editor@indianjurol.com.
6. Names and addresses of individuals who own the newspaper and partners or shareholders holding more than one per cent of the total capital. : Urological Society of India
I, Nitin S. Kekre, hereby declare that the particulars given above are true to the best of my knowledge and belief.
Nitin S. Kekre
Date: 12th April, 2007 Editor

REFERENCES

  • 1.Poulsen A, Schou J, Puggaard L, Torp-Pedersen S, Nordling J. Prostatic enlargement, symptomatology and pressure/flow evaluation: Interrelations in patients with symptomatic BPH. Scand J Urol Nephrol Suppl. 1994;157:67–73. [PubMed] [Google Scholar]
  • 2.Schafer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, et al. Good urodynamic practices: Uroflowmetry, filling cystometry and pressure-flow studies. Neurourol Urodynamics. 2002;21:261–74. doi: 10.1002/nau.10066. [DOI] [PubMed] [Google Scholar]
  • 3.Golomb J, Lindner A, Siegel Y, Korczak D. Variability and circadian changes in home uroflowmetry in patients with benign prostatic hyperplasia compared to normal controls. J Urol. 1992;147:1044–7. doi: 10.1016/s0022-5347(17)37462-1. [DOI] [PubMed] [Google Scholar]
  • 4.Reynard JM, Peters TJ, Lim C, Abrams P. The value of multiple free-flow studies in men with lower urinary tract symptoms. Br J Urol. 1996;77:813–8. doi: 10.1046/j.1464-410x.1996.00097.x. [DOI] [PubMed] [Google Scholar]
  • 5.De la Rosette JJ, Witjes WP, Debruyne FM, Kersten PL, Wijkstra H. Improved reliability of uroflowmetry investigations: Results of a portable home-based uroflowmetry study. Br J Urol. 1996;78:385–90. doi: 10.1046/j.1464-410x.1996.00115.x. [DOI] [PubMed] [Google Scholar]
  • 6.Pel JM, van Mastrigt R. Development of a low-cost flow meter to grade the maximum flow rate. Neurourol Urodyn. 2002;21:48–54. doi: 10.1002/nau.2112. [DOI] [PubMed] [Google Scholar]
  • 7.Currie RJ. The streamtest cup: A new uroflow device. Urology. 1998;52:1118–21. doi: 10.1016/s0090-4295(98)00404-x. [DOI] [PubMed] [Google Scholar]
  • 8.Sonke G, Kortmann BB, Verbeek AL, Kiemeney LA, Debruyne FM, de la Rosette JJ. Variability of pressure-flow studies in men with lower urinary tract symptoms. Neurourol Urodyn. 2000;19:637–56. doi: 10.1002/1520-6777(2000)19:6<637::aid-nau2>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  • 9.Feneley MR, Dunsmuir WD, Pearce J, Kirby RS. Reproducibility of uroflow measurement: Experience during a double-blind, placebo-controlled study of doxazosin in benign prostatic hyperplasia. Urology. 1996;47:658–63. doi: 10.1016/s0090-4295(96)00014-3. [DOI] [PubMed] [Google Scholar]
  • 10.Boci R, Fall M, Waldén M, Knutson T, Dahlstrand C. Home Uroflowmetry: Improved accuracy in outflow assessment. Neurourol Urodyn. 1999;18:25–32. doi: 10.1002/(sici)1520-6777(1999)18:1<25::aid-nau5>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Urology : IJU : Journal of the Urological Society of India are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES